Altered dietary salt intake for people with chronic kidney disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Mcmahon, Emma J ^a,b   Campbell, Katrina L ^a   Bauer, Judith D ^b   Mudge, David W ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; RENIN; SODIUM; SALT INTAKE;

ALDOSTERONE BLOOD LEVEL; BLOOD PRESSURE REGULATION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE EXACERBATION; EDEMA; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; EXTRACELLULAR FLUID; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOTENSION; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY PLASMA FLOW; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM RESTRICTION; SYMPTOM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ADMINISTRATION AND DOSAGE; BLOOD PRESSURE; DIET THERAPY; DRUG EFFECTS; META ANALYSIS; PHYSIOLOGY; SALT INTAKE; SELECTION BIAS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; EDEMA; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; SELECTION BIAS; SODIUM CHLORIDE, DIETARY;

EID: 84934301616     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010070.pub2     Document Type: Review

References (78)

1. de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Dobbie H, Varagunam M, et al. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart 2013;99(17):1256-60. [MEDLINE: 23766446]
2. de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Dobbie H, Yaqoob MM. A dietitian's role in the management of blood pressure: results of a randomised controlled trial in British Bangladeshi chronic kidney disease patients [abstract]. Clinical Nutrition Supplements 2012;7(1):168-9. [EMBASE: 70903810]
3. Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, et al. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis 2013;226(2):459-65. [MEDLINE: 23261172]
4. Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, de Boer RA, et al. Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. Journal of Hypertension 2013; Vol. 31, issue 12:2425-32. [MEDLINE: 24029871]
5. Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011;343:d4366. [MEDLINE: 21791491]
6. Fine A. CAPD patients can take more salt in diet than usually prescribed [abstract]. Nephrology Dialysis Transplantation 1997;12(9):A183. [CENTRAL: CN-00261430]
7. Fine A, Fontaine B, Ma M. Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: results of a double-blind crossover study. Journal of the American Society of Nephrology 1997;8(8):1311-4. [MEDLINE: 9259359]
8. Keven K, Yalcin S, Canbakan B, Kutlay S, Sengul S, Erturk S, et al. The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Transplantation Proceedings 2006;38(5):1323-6. [MEDLINE: 16797292]
9. Konishi Y, Morikawa T, Yasu T, Teramoto K, Okada N, Yoshioka K, et al. Blunted response of the renin-angiotensin system and nitric oxide synthesis related to sodium sensitivity in immunoglobulin A nephropathy. Hypertension Research - Clinical & Experimental 2004;27(1):7-13. [MEDLINE: 15055250]
10. Konishi Y, Nishiyama A, Morikawa T, Kitabayashi C, Shibata M, Hamada M, et al. Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension 2011;58(2):205-11. [MEDLINE: 21670416]
11. Konishi Y, Okada N, Okamura M, Morikawa T, Okumura M, Yoshioka K, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin A nephropathy. Hypertension 2001;38(1):81-5. [MEDLINE: 11463764]
12. Campbell KL, Johnson DW, Bauer JD, Hawley CM, Isbel NM, Stowasser M, et al. A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrology 2014;15(1):57. [MEDLINE: 24708818]
13. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, et al. A randomized trial of dietary sodium restriction in CKD. Journal of the American Society of Nephrology 2013;24(12):2096-103. [MEDLINE: 24204003]
14. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, et al. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial. BMC Nephrology 2012;13(1):137. [MEDLINE: 23082956]
15. Ruilope LM, Casal MC, Guerrero L, Alcázar JM, Férnandez ML, Lahera V, et al. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency. Drugs 1992;44 Suppl 1:94-8. [MEDLINE: 1283591]
16. Krikken JA, Waanders F, Dallinga-Thie GM, Dikkeschei LD, Vogt L, Navis GJ, et al. Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin. Expert Opinion on Therapeutic Targets 2009;13(5):497-504. [MEDLINE: 19397474]
17. Mahmoodi BK, Mulder AB, Waanders F, Spronk HM, Mulder R, Slagman MC, et al. The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria. Journal of Thrombosis & Haemostasis 2011;9(12):2416-23. [MEDLINE: 21972946]
18. Slagman MC, Kwakernaak AJ, Yazdani S, Laverman GD, van den Born J, Titze J, et al. Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects. Nephrology Dialysis Transplantation 2012;27(3):978-82. [MEDLINE: 21778278]
19. Slagman MC, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Laverman GD, et al. Effects of antiproteinuric intervention on elevated Connective Tissue Growth Factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy. Clinical Journal of The American Society of Nephrology: CJASN 2011;6(8):1845-50. [MEDLINE: 21784839]
20. Slagman MC, Sinkeler SJ, Hemmelder MH, Waanders F, Vogt L, Kluin-Nelemans HC, et al. Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrology Dialysis Transplantation 2010;25(10):3256-60. [MEDLINE: 20339099]
21. Slagman MC, Waanders F, Vogt L, Damman K, Hemmelder M, Navis G, et al. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients. Nephrology Dialysis Transplantation 2012;27(3):983-90. [MEDLINE: 21862455]
22. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. Journal of the American Society of Nephrology 2008;19(5):999-1007. [MEDLINE: 18272844]
23. Vogt L, de Zeeuw D, Waanders F, Navis G. Independent and added effects of low sodium and diuretic on renoprotective effect of AII antagonist in non-diabetic proteinuric patients (abstract no: TH-FC171). Journal of the American Society of Nephrology 2005;16:37A. [CENTRAL: CN-00644129]
24. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, et al. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. American Journal of Kidney Diseases 2009;53(1):16-25. [MEDLINE: 18823687]
25. De Nicola L, Bellizzi V, Minutolo R, Cioffi M, Giannattasio P, Terracciano V, et al. Effect of dialysate sodium concentration on interdialytic increase of potassium. Journal of the American Society of Nephrology 2000;11(12):2337-43. [MEDLINE: 11095656]
26. Ekhlas Eid A, Nguyen J, Delcroix C, Moutel M, Esnault VL. Effect of diuretics after dual blockade of renin-angiotensin-aldosterone system on severe proteinuria [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:434-5. [CENTRAL: CN-00509172]
27. Esnault VL, Ekhlas A, Delcroix C, Moutel MG, Nguyen JM. Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents. Journal of the American Society of Nephrology 2005;16(2):474-81. [MEDLINE: 15615822]
28. Esnault VL, Ekhlas A, Nguyen JM, Delcroix C, Moutel MG. Angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB) and diuretics for refractory proteinuria. [abstract no: SU-PO1030]. Journal of the American Society of Nephrology 2003;14(Nov):762A. [MEDLINE: CN-00583888]
29. Forrester DL, Britton J, Lewis SA, Pogson Z, Antoniak M, Pacey SJ, et al. Impact of adopting low sodium diet on biomarkers of inflammation and coagulation: a randomised controlled trial. Journal of Nephrology 2010;23(1):49-54. [MEDLINE: 20091486]
30. Kauric-Klein Z. Blood pressure knowledge in hypertensive hemodialysis patients. Cannt Journal 2012;22(4):18-25. [MEDLINE: 23413535]
31. Kauric-Klein Z. Improving blood pressure control in end stage renal disease through a supportive educative nursing intervention. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 2012;39(3):217-28. [MEDLINE: 22866361]
32. Mahmoodi BK, Mulder AB, Waanders F, Spronk HM, Mulder R, Slagman MC, et al. The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria. Journal of Thrombosis & Haemostasis 2011;9(12):2416-23. [MEDLINE: 21972946]
33. Osanai T, Fujiwara N, Saitoh M, Sasaki S, Tomita H, Nakamura M, et al. Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease. Blood Purification 2002;20(5):466-8. [MEDLINE: 12207094]
34. Rupp JW, Stone RA, Gunning BE. Sodium versus sodium-fluid restriction in hemodialysis: control of weight gains and blood pressures. American Journal of Clinical Nutrition 1978;31(10):1952-5. [MEDLINE: 707354]
35. Suckling RJ, He F, Markandu N. Modest reduction in salt intake lowers blood pressure and urinary albumin excretion in individuals with impaired glucose tolerance and type II diabetes [abstract]. Journal of Human Hypertension 2010;24(10):708. [EMBASE: 70273931]
36. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005;46(2):308-12. [MEDLINE: 15983240]
37. Hwang JH, Chin HJ, Kim S, Kim DK, Kim S, Park JH, et al. Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial. Clinical Journal of the American Society of Nephrology: CJASN 2014;9(12):2059-69. [MEDLINE: 25332317]
38. Rodrigues Telini LS, De Carvalho BG, Caramori JCT, Castro JH, Martin LC, Barretti P. Effect of dietary sodium restriction on body water, blood pressure, and inflammation in hemodialysis patients: A prospective randomized controlled study. International Urology & Nephrology 2014;46(1):91-7. [MEDLINE: 23340794]
39. Clark-Cutaia MN, Ren D, Hoffman LA, Burke LE, Sevick MA. Adherence to hemodialysis dietary sodium recommendations: influence of patient characteristics, self-efficacy, and perceived barriers. Journal of Renal Nutrition 2014;24(2):92-9. [MEDLINE: 24462498]
40. Clark-Cutaia MN, Ren D, Hoffman LA, Snetselaar L, Sevick MA. Psychometric validation of the self-efficacy for restricting dietary salt in hemodialysis scale. Topics in Clinical Nutrition 2013; Vol. 28, issue 4:384-91. [EMBASE: 2013726385]
41. NCT00141609 . A study looking at the effects of a modest reduction in dietary salt intake on blood pressure control in haemodialysis patients. clinicaltrials.gov/ct2/results?term=NCT00141609 (accessed 12 January 2015).
42. NCT00974636 . Lowering salt intake in chronic kidney disease: a pilot randomized crossover trial. clinicaltrials.gov/ct2/results?term=NCT00974636 (accessed 12 January 2015).
43. NCT01015313 . A multi-center, randomized, controlled and prospective pilot study on the effects of intensified sodium management on hospitalization in chronic hemodialysis patients. clinicaltrials.gov/ct2/show/NCT01015313 (accessed 12 January 2015).
44. Al-Solaiman Y, Jesri A, Zhao Y, Morrow JD, Egan BM. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. Journal of Human Hypertension 2009;23(12):826-35. [MEDLINE: 19404315]
45. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 1997;46(1):19-24. [MEDLINE: add]
46. Ang KS, Benarbia S, Boulahrouz R, Stanescu C, Charasse C, Le Cacheux P, et al. Arterial hypertension in the hemodialysis patient. A model of salt-sensitive hypertension in man [L'hypertension arterielle du patient hemodialyse. Un modele d'hypertension sensible au sel chez l'homme]. Archives des Maladies du Coeur et des Vaisseaux 1999;92(8):1023-6. [MEDLINE: 10486658]
47. Ash S, Campbell K, MacLaughlin H, McCoy E, Chan M, Anderson K, et al. Evidence based practice guidelines for the nutritional management of chronic kidney disease. Nutrition & Dietetics 2006;63(Suppl 2):S33-S45. [DOI: 10.1111/j.1747-0080.2006.00100.x]
48. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. Journal of the American Society of Nephrology 2003;14(7 Suppl 2):S131-8. [MEDLINE: 12819318]
49. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney International - Supplement 2003, (87):S24-31. [MEDLINE: 14531770]
50. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298(17):2038-47. [MEDLINE: 17986697]
51. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004;351(13):1296-305. [MEDLINE: 15385656]
52. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998;279(17):1383-91. [MEDLINE: 9582047]
53. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD004022.pub3]
54. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103(7):987-92. [MEDLINE: 11181474]
55. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006;332(7541):563-4. [MEDLINE: 16528062]
56. He FJ, MacGregor GA. How far should salt intake be reduced?. Hypertension 2003;42(6):1093-9. [MEDLINE: 14610100]
57. He FJ, Li J, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD004937.pub2]
58. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
59. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
60. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002;325(7365):628. [MEDLINE: 12242173]
61. Hunsicker LG. The consequences and costs of chronic kidney disease before ESRD. Journal of the American Society of Nephrology 2004;15(5):1363-4. [MEDLINE: 15100382]
62. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GK, et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. American Journal of Nephrology 2006;26(3):268-75. [MEDLINE: 16763384]
63. Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrology Dialysis Transplantation 2009;24(3):956-62. [MEDLINE: 19004849]
64. Korhonen MH, Jarvinen RM, Sarkkinen ES, Uusitupa MI. Effects of a salt-restricted diet on the intake of other nutrients. American Journal of Clinical Nutrition 2000;72(2):414-20. [MEDLINE: 10919936]
65. Kotchen TA, Cowley AW, Frohlich ED. Salt in health and disease--a delicate balance. New England Journal of Medicine 2013;368(13):1229-37. [MEDLINE: 23534562]
66. McMahon EJ, Campbell KL, Mudge D, Bauer JD. Achieving salt restriction in chronic kidney disease. International Journal of Nephrology 2012;epub:10. [PUBMED: 23320173]
67. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005;365(9456):331-40. [MEDLINE: 15664230]
68. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002;39(2 Suppl 1):S1-266. [MEDLINE: 11904577]
69. Ritz E, Koleganova N, Piecha G. Role of sodium intake in the progression of chronic kidney disease. Journal of Renal Nutrition 2009;19(1):61-2. [MEDLINE: 19121773]
70. Siebenhofer A, Jeitler K, Berghold A, Waltering A, Hemkens LG, Semlitsch T, et al. Long-term effects of weight-reducing diets in hypertensive patients. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD008274.pub2]
71. Suckling RJ, He FJ, MacGregor GA. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD006763.pub2]
72. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Archives of Internal Medicine 1999;159(3):285-93. [MEDLINE: 9989541]
73. Thijssen S, Kitzler TM, Levin NW. Salt: its role in chronic kidney disease. Journal of Renal Nutrition 2008;18(1):18-26. [MEDLINE: 18089439]
74. Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland WH, et al. Dietary salt loading impairs arterial vascular reactivity. American Journal of Clinical Nutrition 2010;91(3):557-64. [MEDLINE: 20107199]
75. US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th edition. www.cnpp.usda.gov/DGAs2010-PolicyDocument.htm (accessed 21 January 2015).
76. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. Journal of Internal Medicine 2004;256(4):324-30. [MEDLINE: 15367175]
77. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277(20):1624-32. [MEDLINE: 9168293]
78. McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for chronic kidney disease. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010070]